| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
230,290,000 |
| Market
Cap: |
138.17(K) |
| Last
Volume: |
11,847,187 |
Avg
Vol: |
11,814,278 |
| 52
Week Range: |
$0.0001 - $0.066 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Endo International is a holding company. Through its subsidiaries, Co. is engaged in specialty pharmaceuticals. Co.'s segments are: Branded Pharmaceuticals, which includes branded products to treat and manage conditions in the areas of urology, orthopedics, endocrinology and bariatrics, among others; Sterile Injectables, which consists of branded sterile injectable products; Generic Pharmaceuticals, which includes generic product families that treat and manage a range of medical conditions; and International Pharmaceuticals, which includes products serving therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, oncology and transplantation.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Manogue Caroline B |
Exec. V.P., CLO & Secy |
• – – |
2012-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
12,968 |
24,700 |
|
- |
|
| Manogue Caroline B |
Exec. V.P., CLO & Secy |
• – – |
2012-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
12,968 |
21,767 |
|
- |
|
| Holveck David |
President & CEO |
• • – |
2012-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
52,834 |
104,747 |
|
- |
|
| Holveck David |
President & CEO |
• • – |
2012-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
52,834 |
91,768 |
|
- |
|
| Manogue Caroline B |
Exec. V.P., CLO & Secy |
• – – |
2012-02-21 |
4 |
D |
$35.18 |
$30,853 |
D/D |
(877) |
1,915 |
|
- |
|
| Manogue Caroline B |
Exec. V.P., CLO & Secy |
• – – |
2012-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,792 |
2,792 |
|
- |
|
| Rudio Daniel |
Vice President, Controller |
• – – |
2012-02-21 |
4 |
D |
$35.18 |
$11,167 |
D/D |
(315) |
220 |
|
- |
|
| Spengler William |
Director |
– • – |
2011-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
702 |
22,058 |
|
- |
|
| Scodari Joseph C |
Director |
– • – |
2011-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
695 |
22,554 |
|
- |
|
| Montague William P |
Director |
– • – |
2011-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
165 |
15,397 |
|
- |
|
| Holveck David |
President & CEO |
• • – |
2011-12-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
191,407 |
191,407 |
|
- |
|
| Holveck David |
President & CEO |
• • – |
2011-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
191,407 |
0 |
|
- |
|
| Hyatt Michael |
Director |
– • – |
2011-11-08 |
4 |
S |
$32.31 |
$161,550 |
D/D |
(5,000) |
0 |
|
- |
|
| Hyatt Michael |
Director |
– • – |
2011-11-08 |
4 |
OE |
$11.00 |
$55,000 |
D/D |
5,000 |
5,000 |
|
- |
|
| Montague William P |
Director |
– • – |
2011-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
208 |
15,232 |
|
- |
|
| Holveck David |
President & CEO |
• • – |
2011-08-25 |
4 |
B |
$30.30 |
$248,468 |
D/D |
8,200 |
15,522 |
2.81 |
- |
|
| Manogue Caroline B |
Exec. V.P., CLO & Secy |
• – – |
2011-07-06 |
4 |
AS |
$41.17 |
$847,608 |
D/D |
(20,588) |
0 |
|
- |
|
| Manogue Caroline B |
Exec. V.P., CLO & Secy |
• – – |
2011-07-06 |
4 |
OE |
$16.47 |
$339,084 |
D/D |
20,588 |
20,588 |
|
- |
|
| Spengler William |
Director |
– • – |
2011-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
890 |
20,543 |
|
- |
|
| Scodari Joseph C |
Director |
– • – |
2011-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
741 |
21,055 |
|
- |
|
| Montague William P |
Director |
– • – |
2011-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
223 |
15,024 |
|
- |
|
| Gergel Ivan |
EVP, Research & Development |
• – – |
2011-05-03 |
4 |
AS |
$39.39 |
$492,375 |
D/D |
(12,500) |
0 |
|
- |
|
| Gergel Ivan |
EVP, Research & Development |
• – – |
2011-05-03 |
4 |
OE |
$25.02 |
$312,750 |
D/D |
12,500 |
12,500 |
|
- |
|
| Manogue Caroline B |
Exec. V.P., CLO & Secy |
• – – |
2011-04-05 |
4 |
AS |
$39.90 |
$1,396,500 |
D/D |
(35,000) |
0 |
|
- |
|
| Manogue Caroline B |
Exec. V.P., CLO & Secy |
• – – |
2011-04-05 |
4 |
OE |
$15.24 |
$533,400 |
D/D |
35,000 |
35,000 |
|
- |
|
825 Records found
|
|
Page 8 of 33 |
|
|
